Today: 17 May 2026
Barclays, HSBC shares slide again as oil shock upends UK rate-cut bets

Barclays, HSBC shares slide again as oil shock upends UK rate-cut bets

London, March 4, 2026, 09:37 GMT

  • Investors kept the pressure on UK banks, sending Barclays and HSBC down for another session.
  • Spiking oil and gas prices have stoked fresh inflation worries, delaying anticipated Bank of England rate cuts.
  • Analysts caution that if the energy shock drags on, growth could take a hit and loan-loss risks may climb.

Shares of Barclays and HSBC slid further in London on Tuesday, with UK bank stocks taking another hit as tensions in the Middle East escalated. By 10 a.m. GMT, both banks had dropped roughly 4.5%, according to The Banker.

This drop is hitting just as the UK’s rate outlook remains in flux, with banks making up a big chunk of the FTSE 100. On Tuesday, Britain’s main stock indexes suffered their sharpest single-day slide in nearly a year. Energy prices jumped again, reigniting fears about inflation and forcing investors to dial back bets on interest rate cuts. David Rees, head of global economics at Schroders, flagged the risk: “if higher energy prices squeeze real incomes and prevent the Bank from cutting rates, hopes would be dashed for a growth pick-up.” https://www.reuters.com/world/uk/london-st…

UK shares slumped the previous day, caught in a wider rout as renewed conflict sent oil prices surging and investors flocked to safety. HSBC, Barclays and Lloyds all took hits—drops ranged from 2.5% to 4.2%, according to Reuters. Traders, in turn, scaled back bets on a Bank of England rate cut for later this month. “If the issues persist, then the market will start to worry about new inflationary pressures,” said Dan Coatsworth, head of markets at AJ Bell. https://www.reuters.com/world/uk/uk-stocks…

Oil kept punching higher Wednesday. Brent gained 3.3%, reaching $84.07 a barrel as of 0659 GMT, while U.S. crude added 3% to hit $76.80, according to Reuters. “The primary near-term driver for oil prices remains the US-Iran conflict,” said Kelvin Wong, senior market analyst at OANDA. Traders remain edgy about calling an end to the wild swings. https://www.reuters.com/business/energy/oi…

This shift has knocked the pound lower, feeding bets that the Bank of England could pause on rate cuts. Sterling touched a three-month trough on Tuesday, with traders assigning just a 22% probability to a rate cut at the BoE’s meeting later this month, according to LSEG data cited by Reuters. “We think that in all scenarios the Bank of England will be more sensitive to the upside risks to inflation,” said Paul Dales, chief UK economist at Capital Economics. https://www.reuters.com/world/uk/sterling-…

Barclays, fresh off a notable rally, finds itself in the thick of a valuation debate. On Feb. 25, Simply Wall St flagged that the stock last changed hands at £4.60, while one popular “fair value” model pegged it closer to £4.92, using an 8.38% discount rate to gauge present value from future cash flows. The site showed Barclays had delivered a 60.9% total return over the previous year as of that date—even after sliding 4.2% over the most recent month. https://simplywall.st/stocks/gb/banks/lse-…

Since late February, Barclays has faced an added drag, after investors zeroed in on possible losses linked to the collapse of UK mortgage lender Market Financial Solutions (MFS). Court filings from administrators flagged a potential £930 million gap in collateral, according to Reuters, with just £230 million of “true value” backing loans that totaled £1.16 billion. While some analysts dismissed the risk of broader fallout, the situation put fresh attention on potential trouble lurking in private credit. https://www.reuters.com/business/finance/b…

Commentary aimed at retail investors wasted no time jumping on the volatility. Both Yahoo Finance and The Motley Fool crunched numbers on the latest Barclays share price action, zeroing in on what the moves spell for individual shareholders—and weighing up whether the recent drop leaves the stock looking like a bargain.

Lloyds wasn’t alone. Lenders dropped, and so did airlines and travel stocks earlier this week. Meanwhile, investors picked up energy and defence shares, aiming to shield against the shock.

It all comes down to how long this lasts. Oil and gas prices dropping, tensions cooling—rate cut bets might revive quickly, and banks could recover. But if the energy price spike persists, inflation might prove stubborn, growth could falter, and banks may see more loan defaults with fatter provisions needed.

European shares caught their breath Wednesday, stabilizing after sharp losses, but investor anxiety hasn’t gone far. By 0810 GMT, the STOXX 600 index ticked up 0.6%, according to Reuters. Still, it’s sitting almost 5% below Friday’s record.

Stock Market Today

  • Monster Beverage (MNST) Stock Near Fair Value After Multi-Year Gains
    May 16, 2026, 9:18 PM EDT. Monster Beverage (MNST) has delivered strong returns, rising nearly 89% over five years. The stock recently traded at around $87, modestly above its estimated intrinsic value of $80.02 based on a Discounted Cash Flow (DCF) model. This valuation approach projects Monster's free cash flow growing from $1.94 billion to over $3 billion by 2030. Despite impressive share price gains, the DCF suggests Monster is roughly 8.8% overvalued, indicating current prices are close to fair value rather than significantly overpriced. While the company's position in the US energy drink market supports growth prospects, its valuation score was 0 out of 6 on standard metrics, urging caution for new investors. Traders should monitor valuation shifts and market developments to time entries appropriately.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 04.03.2026

Snowflake edges closer to the sales floor as EY and Canva roll out “agentic” AI platform
Next Story

Snowflake edges closer to the sales floor as EY and Canva roll out “agentic” AI platform

Go toTop